Diabetes Information [Return To Home Page]

Type II Diabetes: Insulin-Dependent Diabetes


The term diabetes refers to higher than normal levels of sugar, or glucose, in the blood. Type II diabetes, also known as insulin-dependent diabetes, was commonly referred to as adult onset diabetes until recently when the name no longer accurately describes the population with this disease.

Type II diabetes, in the past, was relegated to the adult population. However, in the new era of ever rising cases of childhood obesity and heart disease, the term adult onset diabetes is quickly becoming a misnomer. The number of children that are presenting to doctors with this disease is rising at epidemic rates.

Unlike Type I diabetes, where there is little to no insulin being produced by the beta cells of the pancreas, in Type II diabetes there is plenty of insulin. The problem lies in the fact that the cells of the body no longer respond to the insulin. The normal response is to cause gates in the cell membranes to open and letting the sugar in from the blood stream. Since this is not occurring, the sugar levels in the blood remain extremely high and the cells are deprived of the necessary energy that they would normally derive from the sugar.

Additionally, as Type II diabetes is sometimes not diagnosed for many years, the pancreas will sometimes stop producing insulin all together since the body sees no need to make something that can't be used.

Many professionals are prescribing changes in diet and increased activity levels as the medicine needed to help reverse some of the non-responsiveness of the cells to insulin. Making lifestyle changes can dramatically improve the overall health of the patient as well. To augment adjustments in nutrition and exercise, doctors can also prescribe diabetes medication which assists to increase the responsiveness of the cells to the insulin that the body may still be producing.

If left untreated, Type II diabetes can eventually decrease the quality of life and life span of the patient.

Rachel Dayer runs and operates http://www.mustask.com, a health related portal.


MORE RESOURCES:


TopNews United States

Novartis drugs fail to prevent diabetes in the overweight
Xinhua
BEIJING, March 15 (Xinhuanet) -- Novartis AG's (NVS) two drugs have failed to prevent diabetes and the problems it causes in the overweight with poor sugar ...
Drugs in pre-diabetics do little to slow progression to diabetes or to heart ...Los Angeles Times (blog)
Search for Better Diabetes Therapy Falls ShortWall Street Journal
Soy products beat drugs for type 2 diabetes prevention?Food Consumer
BusinessWeek -TopNews United States -Visit Bulgaria
all 20 news articles »


FDA wants label information on diabetes injection
MarketWatch
Byuderon is a once-weekly formulation of exenatide, the active ingredient in Byetta which is used in Type 2 diabetes. In the complete response letter, ...
Byetta LARS: How the FDA's Analysis Paralysis May Aid AmylinSeeking Alpha (blog)
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for ...PR Newswire (press release)
FDA finds flaws at Amylin plantCincinnati Business Courier
Financial News USA (press release)
all 18 news articles »


Forbes (blog)

No heart benefit seen with fibrates in diabetics
Reuters
The study run by the National Institutes of Health, dubbed Accord, aimed to see if the dual-drug therapy could reduce cardiovascular events in diabetes ...
Abbott's TriCor Shows No Benefit For Diabetics In StudyWall Street Journal
Abbott's TriCor With Statin Fails to Cut Diabetic Heart RiskBusinessWeek
ACC: FDA Announces Review of ACCORD DataMedPage Today
Forbes (blog) -PR Newswire (press release) -Benzinga
all 69 news articles »


BBC News

No quick drug fix for high diabetes risk
BBC News
Two key treatments do not halt diabetes in people with early signs of the disease, a large study has found. Researchers said the results showed the only way ...
Workplace fruit - helping keep your diet on trackFruitful Office - Office Fruit News Site (blog)

all 7 news articles »


Effect of Valsartan/Nateglinide on the Incidence of Diabetes and ...
Cardiosource
Study Question: Does use of short-acting insulin secretagogues and/or rennin-angiotensin-blockers reduce the risk of diabetes or cardiovascular (CV) events ...
NAVIGATOR: Valsartan slowed progression to diabetes, no effect on CV eventsEndocrine Today
Navigating the Choices for Diabetes PreventionNew England Journal of Medicine (subscription)
NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk ...PR Newswire (press release)
MedPage Today -RTT News
all 22 news articles »


Swiss stocks - Factors to watch on March 15
Reuters
The diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and ...

and more »


Psychologist helps people cope with diabetes
GoErie.com
D., a psychologist who focuses on helping people with diabetes cope with the stress of having the disease. Studies have shown that people with diabetes have ...
Psychologist helps people cope with diabetesGoErie.com

all 2 news articles »


KolkataObserver.com

Aggressive BP control not effective, possibly harmful, in patients with diabetes
Endocrine Today
ATLANTA – Tight systolic blood pressure control in high-risk patients with diabetes appears to be no more effective in avoiding myocardial infarction, ...
Study: 'Ideal' Blood Pressure Level May Be Too Low For DiabeticsAHN | All Headline News
ACC: Pushing Blood Pressure Too Low May be HarmfulMedPage Today
INVEST: Mortality hazard with lowest blood pressures in diabetics with CAD?TheHeart.Org

all 22 news articles »


Lowering BP risky for patients with diabetes, heart disease
Sify
A University of Florida researcher has urged caution in reducing blood pressure in patients with diabetes and coronary disease. ...


Google News






home | site map
© 2006